Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP1179156.RAKElqbvABbga5S_7wlxgqnQ9iJwTmCfNsoniI1iKaqXw130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP1179156.RAKElqbvABbga5S_7wlxgqnQ9iJwTmCfNsoniI1iKaqXw130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP1179156.RAKElqbvABbga5S_7wlxgqnQ9iJwTmCfNsoniI1iKaqXw130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP1179156.RAKElqbvABbga5S_7wlxgqnQ9iJwTmCfNsoniI1iKaqXw130_provenance.
- NP1179156.RAKElqbvABbga5S_7wlxgqnQ9iJwTmCfNsoniI1iKaqXw130_assertion description "[Several clinical trials have showed that patients with metastatic colorectal cancer (mCRC) who present tumour-promoting mutations in signalling pathways involving the epidermal growth factor receptor (EGFR), which includes activating K-RAS mutations, do not respond to anti-EGFR drugs such as panitumumab and cetuximab.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1179156.RAKElqbvABbga5S_7wlxgqnQ9iJwTmCfNsoniI1iKaqXw130_provenance.
- NP1179156.RAKElqbvABbga5S_7wlxgqnQ9iJwTmCfNsoniI1iKaqXw130_assertion evidence source_evidence_literature NP1179156.RAKElqbvABbga5S_7wlxgqnQ9iJwTmCfNsoniI1iKaqXw130_provenance.
- NP1179156.RAKElqbvABbga5S_7wlxgqnQ9iJwTmCfNsoniI1iKaqXw130_assertion SIO_000772 24793846 NP1179156.RAKElqbvABbga5S_7wlxgqnQ9iJwTmCfNsoniI1iKaqXw130_provenance.
- NP1179156.RAKElqbvABbga5S_7wlxgqnQ9iJwTmCfNsoniI1iKaqXw130_assertion wasDerivedFrom befree-2016 NP1179156.RAKElqbvABbga5S_7wlxgqnQ9iJwTmCfNsoniI1iKaqXw130_provenance.
- NP1179156.RAKElqbvABbga5S_7wlxgqnQ9iJwTmCfNsoniI1iKaqXw130_assertion wasGeneratedBy ECO_0000203 NP1179156.RAKElqbvABbga5S_7wlxgqnQ9iJwTmCfNsoniI1iKaqXw130_provenance.
- befree-2016 importedOn "2016-02-19" NP1179156.RAKElqbvABbga5S_7wlxgqnQ9iJwTmCfNsoniI1iKaqXw130_provenance.